CN104940896A - Capsules for treating eye diseases - Google Patents
Capsules for treating eye diseases Download PDFInfo
- Publication number
- CN104940896A CN104940896A CN201510309015.0A CN201510309015A CN104940896A CN 104940896 A CN104940896 A CN 104940896A CN 201510309015 A CN201510309015 A CN 201510309015A CN 104940896 A CN104940896 A CN 104940896A
- Authority
- CN
- China
- Prior art keywords
- capsules
- capsule
- fructus
- semen
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses capsules for treating eye diseases. The capsules are prepared from the following component extractives in percentage by weight: 10-15% of active polypeptide, 10-15% of arillus longan, 8-10% of medlar, 8-12% of semen cuscutae, 8-12% of radix rehmanniae praeparata, 8-10% of semen cassiae, 3-7% of equisetum hiemale linne, 3-7% of schisandra chinensis, 3-7% of angelica, 5-8% of semen plantaginis, 4-6% of fructus broussonetiae, 2-5% of zanthoxylum, 2-5% of haws, 2-5% of silybum marianum and 2-5% of vitamin A. The capsules provided by the invention have the advantages that active polypeptide can be utilized for tonifying kidney, nourishing liver, supplementing the blood calcium content of a human body, and enhancing the toughness of eyeball walls; arillus longan, equisetum hiemale linne and other components can be utilized for inducing resuscitation and improving eyesight, preventing eyeballs from protruding, lowering the blood sugar content of the human body, improving the crystal osmotic pressure of aqueous humor, and eliminating the fatigue of ciliary muscles of eyes; animal liver extractives and vitamin A can be utilized for supplementing various microelements for the human body, so as to ensure balanced nutritional ingredients of the eyes; after the capsules are taken by a patient, the eye diseases of the patient can be treated fundamentally; the treatment course is short, and the therapeutic effect is instant.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of ocular disorder, be specifically related to a kind of capsule for the treatment of ocular disorder.
Background technology
ocular disorder annoyings daily life always, especially in recent years, along with the increase of life stress and being on the rise of environmental pollution, there is various disease of eye, modal have myopia, amblyopia, the diseases such as astigmatism, relate to crowd extremely wide, little to how old child, large to man at an advanced age, the puzzlement of ocular disease can be subject in each stage that people grow up, the lighter's caligation, need to wear near-sighted glasses, or presbyopic glasses, affect and attractive in appearancely not say, cause life extremely inconvenient, severe one has a strong impact on daily life, cause exophthalmos, one's eyes are lustreless, even blind, for green grass or young crops, middle-aged population, along with increasing of dinner party, the liver diseases such as alcoholic liver also get more and more, liver is impaired, also directly eye eyesight can be affected.Chinese medicine, the Western medicine of existing treatment eyes are a lot, but all there are the problems such as dosage is large, the cycle is long, and therapeutic effect is not good.
Summary of the invention
The object of the invention is the treatment problem existed for eyes common disease in prior art, a kind of capsule of special for treating ocular disorder is provided, this capsule can the kidney invigorating nourishing the liver, item of having one's ideas straightened out, and prevention eyeball becomes convex, eliminate eyelash shape muscle fatigue, supplement human body various trace elements, the nutritional labeling of eyes is balanced, effectively treats the liver diseases such as myopia, amblyopia, astigmatism and alcoholic liver, through clinical trial, therapeutic effect is good.
Technical scheme: a kind of capsule for the treatment of ocular disorder, this capsule is made up of following component extract by weight percentage: active polypeptide 10 ~ 15%, Arillus Longan 10 ~ 15%, Fructus Lycii 8 ~ 10%, Semen Cuscutae 8 ~ 12%, Radix Rehmanniae Preparata 8 ~ 12%, Semen Cassiae 8 ~ 10%, Herba Equiseti Hiemalis 3 ~ 7%, Fructus Schisandrae Chinensis 3 ~ 7%, Radix Angelicae Sinensis 3 ~ 7%, Semen Plantaginis 5 ~ 8%, Fructus Broussonetiae 4 ~ 6%, Pericarpium Zanthoxyli 2 ~ 5%, Fructus Crataegi 2 ~ 5%, Herba Silybi mariani 2 ~ 5%, vitamin A 2 ~ 5%.
Based on technique scheme, above-mentioned capsule is made up of following component extract by weight percentage: active polypeptide 12%, Arillus Longan 12%, Fructus Lycii 9%, Semen Cuscutae 10%, Radix Rehmanniae Preparata 10%, Semen Cassiae 9%, Herba Equiseti Hiemalis extract 5%, Fructus Schisandrae Chinensis 5%, Radix Angelicae Sinensis 5%, Semen Plantaginis 6%, Fructus Broussonetiae 5%, Pericarpium Zanthoxyli 3%, Fructus Crataegi 3%, Herba Silybi mariani 3%, vitamin A 3%.
Beneficial effect of the present invention: the present invention treats the capsule of ocular disorder through clinical trial, on the liver diseases such as treatment myopia, amblyopia, astigmatism and alcoholic liver, effect is good, short treating period, dosage is few, instant effect, does not recur after drug withdrawal, fundamentally can treat ocular disease.Such as: myopia ancients claim " the nearly timid disease far away of energy: namely look nearly thing clear, fuzzy depending on thing far away." Jing-Yue Complete Works volume 27 to say " can not hyperope, YANG QI deficiency also, YANG QI deficiency, then often have a surplus, and sun be that the moon soaks, and brilliance can not be sent out far away, therefore near-sighted thing is clear and thing far away is fuzzy by the moon." modern medicine thinks, myopia be by heredity or nurture bad, axis oculi is extended, or due to ciliary spasm, cause the factors such as curvature of lens change to cause, image of looking for something coking was formed before retina.Easily myopia is there is when human body lacks certain or many kinds of substance, analyze and find that the blood calcium of most myope is on the low side, vitamin A, phylloxanthin lack, blood calcium reduces the tenacity affecting wall of eyeball, makes eyeball elongated, and health blood sugar content increases, crystalline lens osmotic pressure is caused to change, when aqueous humor osmotic pressure is lower than crystalline lens osmotic pressure, aqueous humor will enter crystalline lens, makes crystalline lens become convex and causes myopia.Adolescence requires that regulating power is strong, for closely seeing thing, can constantly regulate, and has the adaptability of height.But the long-time hypertonicity of ciliary muscle, there will be fatigue and spasm, form accommodative myopia, if treated not in time, eliminate ciliary muscle tired, letting alone sustainable development may become irreversible true myopia.
" liver opening at eye " is if the too prosperous health that all can affect eyes of deficiency of liver-blood or irritability.In the present invention, active polypeptide can the kidney invigorating nourishing the liver, the content of blood calcium in added body, strengthen the tenacity of wall of eyeball, the composition such as Arillus Longan, Herba Equiseti Hiemalis can be had one's ideas straightened out improving eyesight, strengthens aqueous humor osmotic pressure, stops aqueous humor to enter crystalline lens, prevention eyeball becomes convex, blood sugar content in body can be reduced, improve the brilliant osmotic pressure of aqueous humor, eliminate eyelash shape muscle fatigue.Animal livers extract and vitamin A can supplement human body various trace elements makes the nutritional labeling of eyes balance.After taking medicine, fundamentally can treat ocular disease, short treating period, instant effect.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be further described, better to understand technical solution of the present invention.
Embodiment 1: a kind of capsule for the treatment of ocular disorder, this capsule is made up of following component extract by weight percentage: active polypeptide 11%, Arillus Longan 10%, Fructus Lycii 10%, Semen Cuscutae 12%, Radix Rehmanniae Preparata 8%, Semen Cassiae 8%, Herba Equiseti Hiemalis 7%, Fructus Schisandrae Chinensis 3%, Radix Angelicae Sinensis 3%, Semen Plantaginis 5%, Fructus Broussonetiae 6%, Pericarpium Zanthoxyli 5%, Fructus Crataegi 5%, Herba Silybi mariani 5%, vitamin A 2%.In the present embodiment, capsule is every 0.45g, is oral medication, 2-3 time on the one, a 2-4 grain, energy liver and kidney tonifying after taking medicine, and benefiting QI and nourishing blood, item of having one's ideas straightened out, as there is the genus normal phenomenon that hardens in drug administration process.Adopt the capsule that the present embodiment formula extract is obtained, to children's and in, young myopia, amblyopia and astigmatism symptom treatment Be very effective.
Embodiment 2: a kind of capsule for the treatment of ocular disorder, this capsule is made up of following component extract by weight percentage: active polypeptide 14%, Arillus Longan 14%, Fructus Lycii 8%, Semen Cuscutae 8%, Radix Rehmanniae Preparata 11%, Semen Cassiae 10%, Herba Equiseti Hiemalis 3%, Fructus Schisandrae Chinensis 6%, Radix Angelicae Sinensis 6%, Semen Plantaginis 6%, Fructus Broussonetiae 4%, Pericarpium Zanthoxyli 2%, Fructus Crataegi 2%, Herba Silybi mariani 2%, vitamin A 4%.In the present embodiment, capsule is every 0.45g, is oral medication, 2-3 time on the one, a 2-4 grain, as there is the genus normal phenomenon that hardens in drug administration process.Can liver and kidney tonifying after taking medicine, benefiting QI and nourishing blood, item of having one's ideas straightened out, during the present embodiment is particularly useful for, elderly population, the liver disease excellent such as, astigmatism, alcoholic liver dim-sighted from old age to treatment.
Embodiment 3: a kind of capsule for the treatment of ocular disorder, this capsule is made up of following component extract by weight percentage: active polypeptide 12%, Arillus Longan extract 12%, Fructus Lycii 9%, Semen Cuscutae 10%, Radix Rehmanniae Preparata 10%, Semen Cassiae 9%, Herba Equiseti Hiemalis extract 5%, Fructus Schisandrae Chinensis 5%, Radix Angelicae Sinensis 5%, Semen Plantaginis 6%, Fructus Broussonetiae 5%, Pericarpium Zanthoxyli 3%, Fructus Crataegi 3%, Herba Silybi mariani 3%, vitamin A 3%.In the present embodiment, capsule is every 0.45g, is oral medication, 2-3 time on the one, a 2-4 grain, as there is the genus normal phenomenon that hardens in drug administration process.Through repeatedly clinical trial, adopt the capsule that the present embodiment formula extracting solution is obtained, to child and in, young myopia, amblyopia and the liver disease therapeutic effect such as astigmatism symptom and alcoholic liver be remarkable.
Adopt the capsule that above-described embodiment formula extracting solution is obtained, clinical trial is as follows:
Case 1: Liu so-and-so, female, 15 years old, flat-top recluse, from little because living habit is bad, study abnormal sitting posture is true, just slight myopic, amblyopia problem is there is 10 years old time, the head of a family did not take notice of at that time, Liu so-and-so can be slight when seeing thing painstaking, but not much outward manifestations, 11 years old time, see that object slightly a little further needs narrow eyes, and expression does not see again and again, the head of a family just draws attention this, just seek medical advice everywhere, eaten various Western medicine, Chinese medicine effect is all not obvious, once drug withdrawal, vision returns to original state again.A chance opportunity, at the beginning of 2014, Liu so-and-so under the head of a family accompanies, come above-described embodiment capsule reagent point, after some row check, find that so-and-so myopia of Liu reaches intermediate stage, after testing, find that so-and-so blood calcium of Liu is on the low side, vitamin A, phylloxanthin famine, for this situation, under physician guidance, Liu so-and-so take above-described embodiment capsule, three times on the one, take half an hour after meal, one time 4, after taking medicine 4 weeks, Liu so-and-so vision obviously improve, distant objects can be seen clearly, but it is more painstaking to be still sensation, continue to take medicine, take medicine the 8th week, Liu so-and-so substantially recover normal level, see that distant objects is not painstaking yet, for the purpose of consolidating, continue again rear drug withdrawal in 4 weeks of taking medicine, drug withdrawal half a year, through tracing observation, so-and-so vision of Liu keeps normal level, without rebound phenomena.
Case 2: high so-and-so, man, 40 years old, people from Ruzhou, table mountain, more because treating with courtesy at ordinary times, be on the drink, there is serious alcoholic liver, what vision was become is very fuzzy, often occurs dizziness and blurred vision phenomenon, does not even see traffic lights when driving, have a strong impact on orthobiosis, seek medical advice everywhere in recent years, eaten various Western medicine, Chinese medicine effect is all not obvious, even more and more serious.The middle ten days in 2014, it is high that so-and-so comes above-described embodiment capsule reagent point upon somebody's introduction, after testing, find that so-and-so blood calcium of Liu is on the low side, alcoholic liver problem is very serious, for this situation, under physician guidance, Liu so-and-so take above-described embodiment capsule, three times on the one, take half an hour after meal, one time 3, after taking medicine 6 weeks, so-and-so vision high is obviously improved, see that thing is no longer smudgy, alcoholic liver disease has very large alleviation after testing, continue to take medicine, take medicine the 10th week, so-and-so vision high recovers normal level, alcoholic liver disease alleviates greatly, for the purpose of consolidating, continue again to take medicine 4 weeks, so-and-so vision indices high recovers normal level, through tracing observation in drug withdrawal 8 months, so-and-so disease high is without rebound phenomena.
Claims (2)
1. treat a capsule for ocular disorder, it is characterized in that: this capsule is made up of following component extract by weight percentage: active polypeptide 10 ~ 15%, Arillus Longan 10 ~ 15%, Fructus Lycii 8 ~ 10%, Semen Cuscutae 8 ~ 12%, Radix Rehmanniae Preparata 8 ~ 12%, Semen Cassiae 8 ~ 10%, Herba Equiseti Hiemalis 3 ~ 7%, Fructus Schisandrae Chinensis 3 ~ 7%, Radix Angelicae Sinensis 3 ~ 7%, Semen Plantaginis 5 ~ 8%, Fructus Broussonetiae 4 ~ 6%, Pericarpium Zanthoxyli 2 ~ 5%, Fructus Crataegi 2 ~ 5%, Herba Silybi mariani 2 ~ 5%, vitamin A 2 ~ 5%.
2. the capsule for the treatment of ocular disorder according to claim 1, is characterized in that: this capsule is made up of following component extract by weight percentage: active polypeptide 12%, Arillus Longan extract 12%, Fructus Lycii 9%, Semen Cuscutae 10%, Radix Rehmanniae Preparata 10%, Semen Cassiae 9%, Herba Equiseti Hiemalis 5%, Fructus Schisandrae Chinensis 5%, Radix Angelicae Sinensis 5%, Semen Plantaginis 6%, Fructus Broussonetiae 5%, Pericarpium Zanthoxyli 3%, Fructus Crataegi 3%, Herba Silybi mariani 3%, vitamin A 3%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510309015.0A CN104940896A (en) | 2015-06-09 | 2015-06-09 | Capsules for treating eye diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510309015.0A CN104940896A (en) | 2015-06-09 | 2015-06-09 | Capsules for treating eye diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104940896A true CN104940896A (en) | 2015-09-30 |
Family
ID=54156319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510309015.0A Pending CN104940896A (en) | 2015-06-09 | 2015-06-09 | Capsules for treating eye diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104940896A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113144101A (en) * | 2021-01-25 | 2021-07-23 | 中科智盟(北京)科技有限公司 | Medicine for correcting vision and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308950A (en) * | 2000-11-24 | 2001-08-22 | 黄培光 | Vision improving pill |
CN1730081A (en) * | 2005-07-22 | 2006-02-08 | 重庆东方药业股份有限公司 | Medicine for treating cataract and process for preparing the same |
CN101757363A (en) * | 2008-11-19 | 2010-06-30 | 赵伟 | Preparation method of five-seed pills |
-
2015
- 2015-06-09 CN CN201510309015.0A patent/CN104940896A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308950A (en) * | 2000-11-24 | 2001-08-22 | 黄培光 | Vision improving pill |
CN1730081A (en) * | 2005-07-22 | 2006-02-08 | 重庆东方药业股份有限公司 | Medicine for treating cataract and process for preparing the same |
CN101757363A (en) * | 2008-11-19 | 2010-06-30 | 赵伟 | Preparation method of five-seed pills |
Non-Patent Citations (1)
Title |
---|
邹远东编著: "《酶法多肽——人类健康卫士》", 31 January 2015, 知识产权出版社有限责任公司 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113144101A (en) * | 2021-01-25 | 2021-07-23 | 中科智盟(北京)科技有限公司 | Medicine for correcting vision and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100473406C (en) | Traditional Chinese medicine preparation for eye health care and asthenopia alleviation | |
CN106236739B (en) | Contain lutein/lutein ester composition and its application | |
CN102188604A (en) | Medicament for treating myopia and presbyopia | |
CN104474018A (en) | Health-care soft capsule for relieving asthenopia | |
CN102742656A (en) | Milky tea relieving asthenopia and preparation method thereof | |
CN109010790A (en) | A kind of composition and its application for improving eye strain | |
CN105106286A (en) | Health product with effects of protecting eyes and improving eyesight | |
CN105031027A (en) | Chinese herbal medicine ointment for treating myopia | |
CN108635461A (en) | Dry eyes atomized liquid | |
CN101129147A (en) | Coix seed milk | |
CN104940896A (en) | Capsules for treating eye diseases | |
CN101647913B (en) | Traditional Chinese medicine preparation for treating senile cataract and viral keratitis | |
CN103585363A (en) | Traditional Chinese medicine composition for treating senile cataract | |
CN101129698B (en) | Eye drops containing turmeric extractive and preparation method thereof | |
CN104474509A (en) | Medicine patch for conditioning eye refraction and preparation method of medicine patch | |
CN105770506A (en) | Traditional Chinese medicine eye drops for alleviating asthenopia and preparation method thereof | |
CN104689107B (en) | It is a kind of to be used to treat Chinese medicine composition of myopia and preparation method thereof | |
CN101856429B (en) | Medicine compound with visual fatigue relieving function and preparation method thereof | |
CN104055841B (en) | A kind for the treatment of and pre-myopic-preventing pharmaceutical composition | |
CN106344827A (en) | Eye drops for treating presbyopia and preparation method of eye drops | |
CN107412539A (en) | Prevent and treat the herbal application of myopia | |
CN108743846A (en) | A kind of improving eyesight cream, improving eyesight water, improving eyesight drink and preparation method thereof | |
CN105983006A (en) | Composition for relieving visual fatigue and preparation method of composition | |
CN109875048A (en) | Eyeshield composition and its application | |
CN105311424B (en) | A kind of Chinese medicine composition and preparation method thereof for treating visual fatigue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150930 |